In the cation of the title compound, C 18 H 20 ClN 4 O 3 S + ÁCl À , the tetrahydropyridinium ring assumes a half-chair conformation. The dihedral angle between the pyrazole ring and the naphthalene ring system is 75.19 (6) . In the crystal, ions are linked into a three-dimensional network by N-HÁ Á ÁO, N-HÁ Á ÁCl and O-HÁ Á ÁCl hydrogen bonds and weakstacking interactions with centroid-centroid distances of 3.608 (2) Å .
Related literature
For general background to potential anticancer kinase inhibitors, see: Fancelli et al. (2005) ; Gadekar et al. (1968) . For a related structure, see: Brehm (1982) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
Comment
As part of our ongoing project aimed at the development of potential anticancer kinase inhibitors (Fancelli et al., 2005; Gadekar et al., 1968) , we have synthesized the title compound and report its crystal structure herein.
In the title compound ( Fig. 1 ) bond lengths and angles have normal values. The dihedral angle between the planes of the pyrazole ring and the naphthalene ring system is 75.19 (6)°. As already observed in the related compound 2-methyl-4,5,6,7-tetrahydro-pyrazolo(3,4-c)pyridin-3-ol monohydrate (Brehm, 1982) the tetrahydropyridinium ring assumes a halfchair conformation, with atom C15 displaced by 0.665 (2) Å from the mean plane through the C12/C13/C14/C16/N3 atoms.
The crystal structure (Fig. 2) is stabilized by N-H···O, N-H···Cl and O-H···Cl hydrogen bonds (Table 1) and by weak π···π stacking interactions occurring between centrosymmetrically related C5-C10 rings (centroid-to-centroid distance = 3.608 (2) Å).
Experimental
A mixture of tert-butyl 3-cyano-4-oxopiperidine-1-carboxylate (22.4 g, 100 mmol) and 2-hydroxyethylhydrazine (7.76 g, 100 mmol) in ethanol was stirred at room temperature for 24 h and concentrated by evaporation, then crystallized in AcOEt and petroleum ether (5:1 v/v) to give tert-butyl 3-amino-2-(2-hydroxyethyl)-6,7-dihydro-2H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate as a yellow solid (13.5 g, one-step yield: 72%). A mixture of a portion (4.0 g, 14.2 mmol) of the material so obtained, azabenzene (10 ml) and dry acetonitrile was stirred at room temperature for 10 min and then a solution of 5-chloronaphthalene-1-sulfonyl chloride (3.7 g, 14.2 mmol) in dry acetonitrile (100 ml) was slowly added dropwise, stirred for 2 additional hours and concentrated by evaporation. The residue was purified by flash chromatography to give 3.9 g of tert-butyl 3-(1-chloronaphthalene-5-sulfonamido)-2-(2-hydroxyethyl)-6,7-dihydro-2H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate as a slightly yellow solid (one-step yield: 54%). Then, dry HCl gas was bubbled in a solution of the material so obtained (3.0 g, 5.9 mmol) in dry DCM (100 ml) for 3 h to get a white solid of the title compound (one-step yield:98%).
Colourless block crystals suitable for X-ray diffraction were obtained in 5 days by slow evaporation of a methanol solution.
Refinement
All H atoms were detected in a difference map. The H-atom bonded to N1 was refined freely, all other H-atoms were placed in calculated positions and refined using a riding motion approximation, with C-H=0.93-0.97 Å, with U iso (H)=1.2U eq (C); N-H=0.90 Å, with U iso (H)=1.2U eq (N); O-H=0.82 Å, with U iso (H)=1.5U eq (O).
supplementary materials sup-2 Figures   Fig. 1 . The molecular structure of the title compound, showing the atomic numbering scheme. Displacement ellipsoids are drawn at the 30% probability level. 
